Research
Hormonal
Semaglutide reduces body mass index mean by up to 16.7% in adolescents with obesity after 68 weeks.
Semaglutide can be effective for weight management in adolescents with obesity.
StrongSupportsmedium confidence
Semaglutide also reduces placebo-subtracted body mass index mean by up to 16.7% in adolescents with obesity after 68 weeks.
Why this rating
Based on a randomized controlled trial.
Source
Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
Natalie Rodríguez et al. · Pharmacological Reviews · 2025
reviewCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →